OrbiMed Advisors LLC
- SEC CIK
- 0001055951
- Latest filing
- Aug 14, 2026
KZR holding history
Kezar Life Sciences, Inc. in every 13F filed by OrbiMed Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
KZR overviewAll 13F holders of KZRFull Q2 2026 holdings
- Shares (Q4 2025)
- 0
- Sold out in Q4 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 16
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 0 | $0 | 0.0% | −192,700−100.0% | Sold out | Holders |
| Q3 2025 | 192,700 | $751.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 192,700 | $882.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 192,700 | $940.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 192,700 | $1.29M | <0.1% | 00.0% | UnchangedConverted for a 1-for-10 split | Holders |
| Q3 2024 | 1,927,000 | $1.49M | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 1,927,000 | $1.16M | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 1,927,000 | $1.74M | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 1,927,000 | $1.83M | <0.1% | −3,536,000−64.7% | Reduced | Holders |
| Q3 2023 | 5,463,000 | $6.50M | 0.2% | 00.0% | Unchanged | Holders |
| Q2 2023 | 5,463,000 | $13.4M | 0.3% | 00.0% | Unchanged | Holders |
| Q1 2023 | 5,463,000 | $17.1M | 0.3% | +878,678+19.2% | Added | Holders |
| Q4 2022 | 4,584,322 | $32.3M | 0.6% | +2,812,622+158.8% | Added | Holders |
| Q3 2022 | 1,771,700 | $15.3M | 0.3% | +351,800+24.8% | Added | Holders |
| Q2 2022 | 1,419,900 | $11.7M | 0.2% | +1,419,900 | New | Holders |
| Q4 2021 | 0 | $0 | 0.0% | −1,150,000−100.0% | Sold out | Holders |
| Q3 2021 | 1,150,000 | $9.94M | 0.1% | +592,809+106.4% | Added | Holders |
| Q2 2021 | 557,191 | $3.03M | <0.1% | +557,191 | New | Holders |